Login

Healthcare

00:10:00
Argenica Therapeutics' Phase 2 Trials and Growing Share Price: A Conversation with CEO Dr. Liz Dallimore | Liz Dallimore, CEO , Argenica Therapeutics Ltd.
00:10:00
Argenica Therapeutics CEO Dr. Liz Dallimore Discusses Development Pathway of ARG-007 | Liz Dallimore, CEO , Argenica Therapeutics Ltd.
00:10:00
Liz Dallimore of Argenica Therapeutics Shares Insights at 2024 TechKnow Invest Roadshow | Liz Dallimore, CEO , Argenica Therapeutics Ltd.
00:10:00
Argenica Therapeutics Shares Insights at the ASX Small and Mid-Cap Conference | Liz Dallimore, CEO , Argenica Therapeutics Ltd.
00:10:00
Argenica Therapeutics Achieves Major Milestone in Phase 2 Stroke Drug Trial | Liz Dallimore, CEO , Argenica Therapeutics Ltd.
00:10:00
Biotalys CEO Kevin Helash on Revolutionizing Crop and Food Protection with Protein-Based Solutions | Kevin Helash ,CEO , Biotalys NV.
00:10:00
Anticipation Peaks as GenXone Launches on NewConnect | Michał Kaszuba, CEO, GenXone SA.
00:10:00
Biotech Innovator GenXone Seeks PLN 4 Million in Equity Crowdfunding | Michał Kaszuba, CEO, GenXone SA.
00:10:00
From Crowdfunding to the Stock Market: GenXone’s Roadmap to NewConnect | Michał Kaszuba, CEO, GenXone SA.
00:10:00
Odinwell CEO Klas Arildsson on What to Expect as Shares Debut on Spotlight Stock Market | Klas Arildsson ,CEO , Odinwell AB.
00:10:00
GenXone CEO Discusses Growth Plans and NewConnect Debut Success | Michał Kaszuba, CEO, GenXone SA.
00:10:00
GenXone Anticipates Demand Surge in Next Pandemic Wave | Michał Kaszuba, CEO, GenXone SA.
00:10:00
Global Leaders in RNAi Therapeutics: Sirnaomics’ Commitment to Patient-Centered Care | Patrick Y. Lu , CEO, Sirnaomics Ltd.
00:10:00
Targeted Therapeutics: Patrick Lu on Sirnaomics' Innovations in RNA Interference for Critical Diseases | Patrick Y. Lu , CEO, Sirnaomics Ltd.
00:10:00
Becoming a Fortune 500 CEO: Brent Saunders on Strategy, Success, and Scaling in Big Pharma | Brent Saunder , CEO, Bausch + Lomb corp.
00:10:00
Innovating Sustainability: Insights from Berry Global's John Vassallo and Jessica Wojnicki Rodriguez at CPHI Milan | John Vassallo - VP Global R&D, Jessica Wojnicki Rodriguez - Sustainability Project Manager, Berry Global

© 2026 Nehu